Chest Pain Pilot Study
Study identifier:D9914C00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Randomized Double-Blind Placebo-Controlled Multi-Centre Pilot Study to Assess Symptom Response in Subjects with Pain or Discomfort in the Chest Receiving Oral Treatment with Esomeprazole 40 mg bid for 4 weeks.
Medical condition
Chest pain
Phase
Phase 3
Healthy volunteers
No
Study drug
Esomeprazole
Sex
All
Actual Enrollment
600
Study type
Interventional
Age
18 Years - 70 Years
Date
Study Start Date: 01 May 2004
Primary Completion Date: 01 Jul 2005
Study Completion Date: 01 Jul 2005
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Contact
AstraZeneca Clinical Study Information
-
-
Investigators
Principal Investigator
AstraZeneca Nexium Medical Sciences Director
AstraZeneca
